Ernexa Therapeutics Inc. (ERNA)

NASDAQ: ERNA · Real-Time Price · USD

1.790

+0.010 (0.56%)

Oct 31, 2025, 12:29 PM EDT - Market open

Ernexa Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2018 - 2019
Period Ending	Oct '25 Oct 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2018 - 2019
Market Capitalization	14	15	10	17	217	-	Upgrade
Market Cap Growth	128.85%	55.53%	-41.17%	-92.39%	-	-	Upgrade
Enterprise Value	10	49	45	6	196	-	Upgrade
Last Close Price	1.78	4.41	26.92	48.30	1251.00	-	Upgrade
PS Ratio	10.59	25.95	142.82	-	-	-	Upgrade
PB Ratio	3.00	8.88	4.35	1.36	8.51	-	Upgrade
P/TBV Ratio	5.69	-	51.66	1.64	9.25	-	Upgrade
EV/Sales Ratio	20.35	83.40	658.24	-	-	-	Upgrade
Debt / Equity Ratio	0.13	0.40	18.74	0.10	0.11	0.38	Upgrade
Asset Turnover	0.02	0.02	0.00	-	-	-	Upgrade
Quick Ratio	1.69	0.74	1.22	1.62	4.81	0.52	Upgrade
Current Ratio	1.81	0.80	1.46	1.79	5.10	0.55	Upgrade
Return on Equity (ROE)	-	-2264.31%	-302.20%	-130.70%	-739.07%	-83.79%	Upgrade
Return on Assets (ROA)	-27.19%	-39.64%	-36.19%	-63.25%	-77.17%	-32.34%	Upgrade
Return on Capital (ROIC)	-32.16%	-46.41%	-45.05%	-81.98%	-88.41%	-43.53%	Upgrade
Earnings Yield	-320.19%	-294.88%	-223.12%	-148.88%	-56.47%	-	Upgrade
FCF Yield	-105.80%	-107.29%	-210.34%	-128.86%	-10.89%	-	Upgrade
Buyback Yield / Dilution	-704.66%	-156.81%	-74.17%	-40.92%	-146.19%	-	Upgrade

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q